Filters
on 28 May 2019
ADAPTIVE BIOTECHNOLOGIES CORP.
1853147 · 18 Aug 2017
001
Class 001
Chemical Products
005
Class 005
Pharmaceutical Products
Targeted T-cell receptor sequences, engineered T-cell receptor sequences, and therapeutics derived from natural T-cell receptor sequences for use in the treatment of cancer, autoimmune disease and infectious diseases; pharmaceuticals, medical and veterinary preparations; assays and reagents
...
Class 042
Computer & Software Services & Scientific Services
Scientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies
Scientific research, development and analytical services for discovery...
on 14 Mar 2017
ADAPTIVE BIOTECHNOLOGIES CORP.
1755444 · 18 Nov 2015
042
Class 042
Computer & Software Services & Scientific Services
044
Class 044
Medical, Beauty & Agricultural Services
Scientific and technological services and research and design relating thereto; scientific research, development, engineering, testing, scientific research consultation, and analytical services in the fields of medicine, oncology, hematology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune sequencing, immune repertoire quantitation and sequencing, diagnostics, pharmaceuticals, genetics, gene expression, genetics testing, vaccines and vaccine development, biotechnology, T-cell therapeutics, antibody development and therapeutics, and therapeutic technologies; development of new technology for others in the fields of medicine, oncology, hematology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune sequencing, immune repertoire quantitation and sequencing, diagnostics, pharmaceuticals, genetics, genetics testing, vaccines and vaccine development, biotechnology, T-cell therapeutics, antibody development and therapeutics, and therapeutic technologies; DNA screening and analysis services; genome amplification; genotyping services for research or analysis purposes; medical and scientific research in the fields of cancer biology and diagnosing and treating cancer; providing medical and scientific research information in the field of clinical trials; scientific research in the field of relative and absolute quantitation of adaptive immune cells in a complex biological sample; scientific research for providing relative and absolute quantitation of adaptive immune cells in a solid tumor sample; scientific research for estimating the relative representation of tumor infiltrating T cells in a solid tumor; scientific research for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors; research and development for quantifying the presence and clonality of tumor infiltrating lymphocytes in solid tumors. scientific research, development, engineering, testing, and analytical services for identifying polypeptide pairs of adaptive immune receptor heterodimers of the immune system; scientific research, development, engineering, testing, and analytical services for analyzing and quantifying the diversity of the immune system; scientific research, development, engineering, testing, and analytical services for discovering immune targets; scientific research, engineering, testing, and analytical services for developing monoclonal antibodies and epitope mapping; scientific research for providing sequencing data and analysis of the immune system for vaccine development and vaccine optimization; research and development of vaccines, immunotherapies, and diagnostics; providing technology consultation and research services in the field of immune repertoire analysis, personalized medicine, vaccines, immunotherapies, and diagnostics; scientific research for providing computational analysis of the immune repertoire; providing clinical diagnostic assays and diagnostic or prognostic testing for detection of minimal residual disease in lymphoid malignancies; providing analysis, evaluation, and clinical reports of a patient's immune repertoire, including T cell or B cell clonal diversity and clone frequency; providing assays for tracking clones in an immune repertoire over time; providing diagnostic assays and diagnostic or prognostic testing for residual disease, and the analysis, evaluation, and reports of those test results to help healthcare professionals determine a patient's clinical diagnosis, prognosis or treatment, to assess the effectiveness of patient treatments, and to revise future treatments accordingly; research, development, engineering, testing, and analytical services in the fields of vaccines, screening and detecting diseases, medicine, and therapeutics; research and development of vaccines, immunotherapies, medical diagnostics kits, and therapeutics. research and development of diagnostic test kits for screening and detecting diseases; laboratory research and testing services relating to vaccines, screening and detecting diseases, medicine, and therapeutics; computer services; design and development of computer hardware and software; computer services, namely, software as a service (SAAS) services featuring software that provides information, test results for screening and detecting diseases, and the analysis, evaluation, and reporting of those test results to healthcare professionals and patients; research and diagnostic services for identifying antigen-specific T cells for therapeutic use; Medical services; medical analysis and diagnostic services; medical diagnostic services, namely, medical testing for diagnostic or treatment purposes; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; providing medical diagnostic testing for the treatment of cancer; providing medical testing for immune responses to immunotherapy or cancer treatment; providing medical quantitative analysis and testing services in the fields of cancer biology, immunology, pharmaceuticals and vaccines for diagnostic or treatment purposes; medical testing for the prognosis and staging of patients with solid tumors for treatment purposes; therapeutic services; therapeutic services for the treatment of diseases; therapeutic services for the treatment of cancer
Scientific and technological services and research and design relating...
on 25 May 2023
ADAPTIVE PHAGE THERAPEUTICS INC.
2260322 · 25 May 2023
001
Class 001
Chemical Products
Diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising reagents for testing bacteria sensitivity
005
Class 005
Pharmaceutical Products
Human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity
...
Class 009
Computer & Software Products & Electrical & Scientific Products
Computer software system for identifying precision therapy for treatment of bacterial infections
Class 011
Environmental Control Instrument Products (lighting,heating,cooling,cooking)
Refrigerators and freezers for medical storage purposes
Class 040
Treatment & Processing of Materials Services
Custom manufacture of bacteriophage therapeutics
Diagnostic reagents for clinical and medical laboratory use; diagnosti...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Adaptive biotechnologies corp. (2)
Adaptive phage therapeutics inc. (1)
Categories
Class 1 (2)
Class 5 (2)
Class 42 (2)
Class 9 (1)
Class 11 (1)
Class 40 (1)
Class 44 (1)
Correspondents
Piasetzki nenniger kvas llp (2)
Mbm intellectual property agency (1)
Image Search
Drag and drop or upload to search any image